Integra Lifesciences Holdings Corp. Files SEC Form S-8, Securities To Be Offered To Employees in Employee Benefit Plans: (May 23, 2019)

Health & Medicine Business Daily |

2019 JUN 12 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Business Daily -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Integra Lifesciences Holdings Corp. (Form S-8) was posted on .

The SIC code for this company is 3841, Surgical and Medical Instruments and Apparatus.

The SEC file number is 0001193125-19-155388.

The contact information for this company is 311 ENTERPRISE DRIVE, PLAINSBORO NJ 08536, 6092750500.

Our editors provided additional information about Form S-8: This form is used for the registration of securities to be offered to an issuer’s employees pursuant to certain plans.

A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.

For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/917520/0001193125-19-155388-index.html.

(Our reports deliver fact-based news of research and discoveries from around the world.)

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

INTERVIEW: CEO Steve Stanulis - Stanulis Films

Equities.com's Sam Mitchell interviewing CEO Steve Stanulis of Stanulis Films.